Primary Record
Pyrromycin
- In stock
- 5,036 g
- Purity
- 99.4 %
- CAS
- 668-17-7
Compound Identifiers & Properties
- CAS
- 668-17-7
- PubChem CID
- 196990
- SMILES
- CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)O
- Canonical SMILES
- CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)ccc(O)c2C3=O)[C@H]1C(=O)OC
Names & Synonyms
- Pyrromycin
- Pyromycin
- Pyyromycin
- Ciclamycin 6
- Antibiotic MA 144T2
- Spectrum_001680
- Antibiotic MA-144T2
- RefChem:930423
- Spectrum2_000694
- Spectrum3_000229
- Spectrum4_000945
- Spectrum5_000895
- CCRIS 2264
- AC1L52ON
- BSPBio_001877
- KBioGR_001530
- KBioSS_002160
- SPECTRUM201604
- MA144 T2
- SPBio_000847
- orb1740577
- CHEMBL3039044
- NSC 267229
- SCHEMBL26627913
- SCHEMBL29642861
- ERK5-7G07
- KBio2_002160
- KBio2_004728
- KBio2_007296
- KBio3_001377
- CHEBI:166594
- C30H35NO11
- HMS1923A19
- NSC-267229
- 668-17-7
- MA-144T2
- BBF-02154
- CCG-39695
- CID196990
- HY-N14539
- MA-144T-2
- C30-H35-N-O11
- NCGC00178933-01
- NCGC00178933-02
- J14.232H
- LS-93908
- methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
- SR-05000002759
- SR-05000002759-1
- 1-Naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2
- (1R-(1alpha,2beta,4beta))-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1-naphthacenecarboxylic acid, methyl ester
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R,2R,4S)-
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1-alpha,2-beta,4-beta))-
- (1R)-2-Ethyl-1,2,3,4,6,11-hexahydro-2alpha,5,7,10-tetrahydroxy-6,11-dioxo-4alpha-[[2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic acid methyl ester
- (1R)-2-Ethyl-1,2,3,4,6,11-hexahydro-2alpha,5,7,10-tetrahydroxy-6,11-dioxo-4alpha-[[3-(dimethylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-1beta-naphthacenecarboxylic acid methyl ester
- (1R-(1 alpha,2 beta,4 beta))-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1-naphthacenecarboxylic acid, methyl ester
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
- methyl (1R,2R,4S)-4-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate